Trademarkia Logo

Australia

AU$
MABETULENE
Accepted: In opposition period

Last updated on 17 May 2025

Owner Info

Gerosynth Laboratories Inc.

8535 230th Street East

Lakeville MN 55044, UNITED STATES OF AMERICA

Serial Number

2546023 filed on 1 Apr 2025

Correspondent

Greg Gronholm Gronholm Patent Services

96 Craig Street, Suite 112-318,

East Ellijay GA 30540,

UNITED STATES OF AMERICA

MABETULENE

Classification Information


Class [001]
Active chemical ingredients for use in the manufacture of anti-cancer drugs.

Class [005]
Biological preparations for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for t Read More

Mark Details


Serial Number

2546023

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

7 Oct 2024

Mark Type

US

Legal History


Show more

Status DateAction Taken
17th May 2025Application Accepted correspondence sent
16th May 2025IP Right has been Examined
16th May 2025IP Right Acceptance Published
16th May 2025Status change to Accepted
12th May 2025Awaiting examination
12th May 2025Examination expedited
8th May 2025IP Right Filed Published
8th May 2025Status change to Published
8th May 2025Status change to Filed
8th May 2025IP right goods and service classes updated